Published on: Feb 15, 2017 at MDLinx

Chemotherapy and survival benefit in elderly patients with advanced gastric cancer

By : MDLinx

A new scoring system developed to help clinicians assess whether elderly patients would benefit from chemo was presented at ASCO’s 2017 Gastrointestinal Cancers Symposium. Check it out and other abstracts shared at the conference here.

Read More